chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Small patch of shingles on right butt cheek; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 11Apr2021 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) for unknown indication, from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 21Mar2021 at 12:00 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. On 13Apr2021 at 01:00, the patient experienced small patch of shingles on right butt cheek. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event small patch of shingles on right butt cheek was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Gait disturbance, Influenza, Muscular weakness, Oxygen saturation
Clinical narrative: my blood oxygen was perhaps a point or two lower than my normal readings (95%-98%) for a few days.; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 75-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8727 and expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Right on 19Mar2021 at 13:00 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included glucose tolerance impaired, drug hypersensitivity. The patient's concomitant medications were not reported. The patient received dose 1 of bnt162b2 on 24-FEB-2021 for Covid-19 immunisation (vaccine location: Right arm). The patient experienced my blood oxygen was perhaps a point or two lower than my normal readings (95%-98%) for a few days, i woke up feeling like i had a awful case of the flu: muscle weakness, gait instability, temp 101.2f. vomited once. no diarrhea.  one day later i felt much better: my temperature subsided over the next 3 days to normal, and all the other symptoms dis, on 10Apr2021 at 12:00. Laboratory test includes body temperature: 101.2 fahrenheit, oxygen saturation: 95%-98%, sars-cov-2 antibody test negative: negative. The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received by the patient. Outcome of the events was recovered on an unknown date.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pyrexia, SARS-CoV-2 antibody test negative, Vomiting
Clinical narrative: my blood oxygen was perhaps a point or two lower than my normal readings (95%-98%) for a few days.; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 75-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8727 and expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Right on 19Mar2021 at 13:00 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included glucose tolerance impaired, drug hypersensitivity. The patient's concomitant medications were not reported. The patient received dose 1 of bnt162b2 on 24-FEB-2021 for Covid-19 immunisation (vaccine location: Right arm). The patient experienced my blood oxygen was perhaps a point or two lower than my normal readings (95%-98%) for a few days, i woke up feeling like i had a awful case of the flu: muscle weakness, gait instability, temp 101.2f. vomited once. no diarrhea.  one day later i felt much better: my temperature subsided over the next 3 days to normal, and all the other symptoms dis, on 10Apr2021 at 12:00. Laboratory test includes body temperature: 101.2 fahrenheit, oxygen saturation: 95%-98%, sars-cov-2 antibody test negative: negative. The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received by the patient. Outcome of the events was recovered on an unknown date.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pain
Clinical narrative: Body aches; Temp of 101.7 orally.; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old patient of unspecified gender received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 14Apr2021 at 08:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa and COVID-19.  Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol/ norgestimate (ORTHO TRI-CYCLEN) from an unknown date for an unknown indication and unknown if ongoing. On 21Apr2021 at 19:30, the patient had a temperature of 101.7 (unspecified units) orally, chills, body aches and fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events temperature of 101.7 (unspecified units) orally, chills, body aches and fatigue were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Hyperhidrosis, Influenza like illness
Clinical narrative: Body aches; Flu like symptoms; Chills; Body sweats; Exhaustion; Temp 102F; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Apr2021 at 01:30, 12 hours after vaccine, the patient experienced flu like symptoms, chills, body sweats, body aches, exhaustion and temp 102F. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events flu like symptoms, chills, body sweats, body aches, exhaustion and temp 102F were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body aches; Flu like symptoms; Chills; Body sweats; Exhaustion; Temp 102F; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 15:00, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Apr2021 at 01:30, 12 hours after vaccine, the patient experienced flu like symptoms, chills, body sweats, body aches, exhaustion and temp 102F. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of events flu like symptoms, chills, body sweats, body aches, exhaustion and temp 102F were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Have a fever of 100.7; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 12Apr2021 at 14:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and formoterol fumarate, mometasone furoate (DULERA) from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021 at 11:00, the patient experienced fever of 100.7 (unspecified units). On 22Apr2021 at 11:00, the patient checked his body temperature measured and it was 100.7(unspecified units).The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had a fever of 100.7 was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Disease recurrence, Herpes zoster
Clinical narrative: Shingles; Had shingles 3 years ago and got shingles again; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 28Mar2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included "lupus SLE" (systemic lupus erythematosus) and Sjogren's syndrome. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included prednisone (MANUFACTURER UNKNOWN); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received codeine (MANUFACTURER UNKNOWN), ascorbic acid; eucalyptus globulus oil; echinacea purpurea (ECHINACEA), sulfur (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in the left arm on 07Mar2021 at 08:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was reported that the patient had shingles 3 years ago, on 18Apr2021 at 18:00, the patient got shingles again after the second dose COVID vaccine. It was reported that it was possibly, the vaccine reactivated the virus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included treatment with VIRLEX. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy rashes all over my body; This is a spontaneous report from a contactable healthcare professional, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 10:45 as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced itchy rashes all over body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itchy rashes all over the body was recovering at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 12:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Pain
Clinical narrative: Body aches and sore; swollen lymph node in armpit of injection site arm.; sore, swollen lymph node in armpit of injection site arm.; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0153) via an unspecified route of administration on an unknown date(at the age of 36-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 18Apr2021, the patient experienced body aches and sore, swollen lymph node in armpit of injection site arm. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches and sore, swollen lymph node in armpit of injection site arm was recovering at time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: On day 10 after first shot I developed a red rash; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732) via an unspecified route of administration in the right arm on 01Apr2021 at 13:15 (at the age of 63-year-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0171) via an unspecified route of administration in the  right arm on 22Apr2021 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and adhesive tape allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN), alprazolam (MANUFACTURER UNKNOWN) and famotidine (PEPCID) all for unknown indications on unknown dates and unknown if ongoing. On 11Apr2021 at 14:00, on day 10 after first shot, the patient developed a red rash. The adverse events did not result in doctor or other health care professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of red rash and included treatment with BENADRYL. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red rash was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: The following morning I woke up with a headache; The following morning I woke up with a headache, that progressed into lack of appetite; The following morning I woke up with a headache, that progressed into lack of appetite, fatigue; The following morning I woke up with a headache, that progressed into lack of appetite, fatigue, chills; The following morning I woke up with a headache, that progressed into lack of appetite, fatigue, chills, joint aches; I had a low grade fever in the evening on Sunday 4/18.; I became nauseous around 10pm on 4/17.; This is a spontaneous report from a non-contactable healthcare professional. A 27-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0169) via an unspecified route of administration on the right arm on 17Apr2021 at 08:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The medical history included asthma, COVID-19 and allergy to sulfa drugs. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously took azithromycin(ZITHROMAX) and experienced allergy. On 17Apr2021 at 22:00, the patient became nauseous. On 18Apr2021, the patient woke up in the morning with a headache, that progressed into lack of appetite, fatigue, chills, joint aches and in the evening the patient also had a low grade fever. The patient reported that she did not go to work on 19Apr2021 (Monday) due to lingering fatigue. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nauseous, headache, fatigue, chills, lack of appetite, joint aches and low grade fever was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: The following morning I woke up with a headache; The following morning I woke up with a headache, that progressed into lack of appetite; The following morning I woke up with a headache, that progressed into lack of appetite, fatigue; The following morning I woke up with a headache, that progressed into lack of appetite, fatigue, chills; The following morning I woke up with a headache, that progressed into lack of appetite, fatigue, chills, joint aches; I had a low grade fever in the evening on Sunday 4/18.; I became nauseous around 10pm on 4/17.; This is a spontaneous report from a non-contactable healthcare professional. A 27-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0169) via an unspecified route of administration on the right arm on 17Apr2021 at 08:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The medical history included asthma, COVID-19 and allergy to sulfa drugs. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously took azithromycin(ZITHROMAX) and experienced allergy. On 17Apr2021 at 22:00, the patient became nauseous. On 18Apr2021, the patient woke up in the morning with a headache, that progressed into lack of appetite, fatigue, chills, joint aches and in the evening the patient also had a low grade fever. The patient reported that she did not go to work on 19Apr2021 (Monday) due to lingering fatigue. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nauseous, headache, fatigue, chills, lack of appetite, joint aches and low grade fever was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature fluctuation, Cardiac flutter, Chills, Confusional state
Clinical narrative: tremors; heart was fluttering a lot; palpitations/heart was fluttering a lot; headache; stiff neck; neck pain; GI distress; temperature up and down; jittery; Hot and cold flashes; confusion; Swelling and chills; Swelling and chills; muscle got really tightened, couldn't move around things; This is a spontaneous report from a contactable consumer (patient). This 48-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0150) via an unspecified route of administration 06Apr2021 (at the age of 48-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, fibromyalgia, tremors and movement disorder issues. Concomitant medications included medical marijuana and albuterol from unknown dates for unknown indications. On unspecified dates the patient experienced a little palpitations/heart was fluttering a lot, swelling, chills, headache, stiff neck, tremors, neck pain, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, hot and cold flashes, and some confusion. Somebody had mentioned to the patient anaphylactic shock but she never had an anaphylactic shock. The neck pain was going on for about a week. It was subsiding slightly. The confusion seemed to also had subsided from the last 2 days or so (as of 19Apr2021). The tremors were the primary issue the patient was having. The patient was going to visit a neurophysiologist as a result of the events before the second dose of BNT162B2 to make sure it was safe. The patient received treatment with aspirin and then low dose aspirin, a vitamin, bismuth salicylate (PEPTOBISMOL) for GI distress, and medical marijuana. The outcome of tremors was not recovered. The outcomes of neck pain and confusion were recovering. The outcomes of palpitations, swelling, chills, headache, stiff neck, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, and hot and cold flashes were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling jittery, Feeling of body temperature change, Headache, Muscle tightness, Musculoskeletal stiffness
Clinical narrative: tremors; heart was fluttering a lot; palpitations/heart was fluttering a lot; headache; stiff neck; neck pain; GI distress; temperature up and down; jittery; Hot and cold flashes; confusion; Swelling and chills; Swelling and chills; muscle got really tightened, couldn't move around things; This is a spontaneous report from a contactable consumer (patient). This 48-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0150) via an unspecified route of administration 06Apr2021 (at the age of 48-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, fibromyalgia, tremors and movement disorder issues. Concomitant medications included medical marijuana and albuterol from unknown dates for unknown indications. On unspecified dates the patient experienced a little palpitations/heart was fluttering a lot, swelling, chills, headache, stiff neck, tremors, neck pain, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, hot and cold flashes, and some confusion. Somebody had mentioned to the patient anaphylactic shock but she never had an anaphylactic shock. The neck pain was going on for about a week. It was subsiding slightly. The confusion seemed to also had subsided from the last 2 days or so (as of 19Apr2021). The tremors were the primary issue the patient was having. The patient was going to visit a neurophysiologist as a result of the events before the second dose of BNT162B2 to make sure it was safe. The patient received treatment with aspirin and then low dose aspirin, a vitamin, bismuth salicylate (PEPTOBISMOL) for GI distress, and medical marijuana. The outcome of tremors was not recovered. The outcomes of neck pain and confusion were recovering. The outcomes of palpitations, swelling, chills, headache, stiff neck, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, and hot and cold flashes were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Palpitations, Swelling, Tremor
Clinical narrative: tremors; heart was fluttering a lot; palpitations/heart was fluttering a lot; headache; stiff neck; neck pain; GI distress; temperature up and down; jittery; Hot and cold flashes; confusion; Swelling and chills; Swelling and chills; muscle got really tightened, couldn't move around things; This is a spontaneous report from a contactable consumer (patient). This 48-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0150) via an unspecified route of administration 06Apr2021 (at the age of 48-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, fibromyalgia, tremors and movement disorder issues. Concomitant medications included medical marijuana and albuterol from unknown dates for unknown indications. On unspecified dates the patient experienced a little palpitations/heart was fluttering a lot, swelling, chills, headache, stiff neck, tremors, neck pain, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, hot and cold flashes, and some confusion. Somebody had mentioned to the patient anaphylactic shock but she never had an anaphylactic shock. The neck pain was going on for about a week. It was subsiding slightly. The confusion seemed to also had subsided from the last 2 days or so (as of 19Apr2021). The tremors were the primary issue the patient was having. The patient was going to visit a neurophysiologist as a result of the events before the second dose of BNT162B2 to make sure it was safe. The patient received treatment with aspirin and then low dose aspirin, a vitamin, bismuth salicylate (PEPTOBISMOL) for GI distress, and medical marijuana. The outcome of tremors was not recovered. The outcomes of neck pain and confusion were recovering. The outcomes of palpitations, swelling, chills, headache, stiff neck, gastrointestinal (GI) distress, temperature up and down, jittery, muscle got really tightened, couldn't move around things, and hot and cold flashes were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: General, mild, flu-like symptoms; Headache; Brain fog; Muscle aches; Skin sensitivity; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 06:00, the patient experienced general, mild, flu-like symptoms the day following the injection. The patient also experienced headache, brain fog, muscle aches, skin sensitivity and mild fever. Appetite and digestion seemed to be normal. On day two, symptoms seemed to be declined quickly, saved for a bit of brain fog. Largely as he might have expected, just reporting it to assist with data collection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events general, mild, flu-like symptoms, headache, brain fog, muscle aches, skin sensitivity and mild fever were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Sensitive skin
Clinical narrative: General, mild, flu-like symptoms; Headache; Brain fog; Muscle aches; Skin sensitivity; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 06:00, the patient experienced general, mild, flu-like symptoms the day following the injection. The patient also experienced headache, brain fog, muscle aches, skin sensitivity and mild fever. Appetite and digestion seemed to be normal. On day two, symptoms seemed to be declined quickly, saved for a bit of brain fog. Largely as he might have expected, just reporting it to assist with data collection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events general, mild, flu-like symptoms, headache, brain fog, muscle aches, skin sensitivity and mild fever were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Ear pain, Neck pain, Oropharyngeal pain, Pain
Clinical narrative: Intense neck pain; Overall aches; Low fever; Painful sore throat/ears; Painful sore throat/ears; Injection site is still painful and red; Injection site is still painful and red; Injection site is still painful and red w/large sub-dermal knot; Sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips); This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included cutaneous lupus and Sjogren's syndrome. The patient was allergic to nickel. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL), ascorbic acid  (VITAMIN C), sambucus nigra (ELDERBERRY), melatonin (MANUFACTURER UNKNOWN) and help hair (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 20:00, the patient experienced continuous changes of intense neck pain, overall aches, low fever, painful sore throat/ears and injection site was painful and red with large sub-dermal knot. On an unknown date in Apr2021, the patient experienced sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips). On an unknown date in Apr2021, 1 week later, the events were still present along with the most recent joint pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intense neck pain, overall aches, low fever, painful sore throat, painful sore ears, sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips) and injection site painful and red with large sub-dermal knot were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Intense neck pain; Overall aches; Low fever; Painful sore throat/ears; Painful sore throat/ears; Injection site is still painful and red; Injection site is still painful and red; Injection site is still painful and red w/large sub-dermal knot; Sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips); This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included cutaneous lupus and Sjogren's syndrome. The patient was allergic to nickel. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL), ascorbic acid  (VITAMIN C), sambucus nigra (ELDERBERRY), melatonin (MANUFACTURER UNKNOWN) and help hair (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 20:00, the patient experienced continuous changes of intense neck pain, overall aches, low fever, painful sore throat/ears and injection site was painful and red with large sub-dermal knot. On an unknown date in Apr2021, the patient experienced sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips). On an unknown date in Apr2021, 1 week later, the events were still present along with the most recent joint pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intense neck pain, overall aches, low fever, painful sore throat, painful sore ears, sharp/stabbing joint pain (wrists, elbows, shoulders, knees, hips) and injection site painful and red with large sub-dermal knot were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: Fever of 101.9F; Muscle aches accompanied the fever but were mostpresent in the first 24 hours.; Soreness in the left arm where vaccine was administered; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 14:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history was not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have any other medications in two weeks. The patient had no known allergies. On 16Apr2021, 16 hours after the vaccination, the patient experienced fever of 101.9 degree Farenheit (degF), which lasted for approximately 48 hours. Also experienced the muscle aches which accompanied the fever but were most present in the first 24 hours and soreness in the left arm where vaccine was administered. On 16Apr2021 at 06:30, 16 hours after the vaccination, the patient underwent lab test which included body temperature and result was 109 (degF). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever of 101.9 (degF), muscle aches and vaccination site soreness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Skin induration
Clinical narrative: Localized erythema; Mild induration; Tenderness beyond area of injection approximately 10cm x 7-8 cm starting 2 days after injection; This is a spontaneous report from a contactable physician. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the arm left on 15Apr2021 at 14:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa drugs. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via intramuscular route of administration in the arm left on 18Mar2021 at 15:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, 2 days after vaccination, the patient experienced localized erythema, mild induration and tenderness beyond area of injection approximately 10cm x 7-8 cm on vaccinated arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events localized erythema, mild induration, tenderness beyond area of injection approximately 10cm x 7-8 cm starting 2 days after injection were unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea; Vomiting; Severe headaches; Fever 102; This is a spontaneous report from a contactable nurse. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an intramuscular route of administration in the left arm on 21Apr2021 at 16:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included asthma, anxiety and shellfish intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ethinylestradiol; norgestimate (TRI LO MILI) taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an intramuscular route of administration in the left arm on 31Mar2021 at 16:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 22Apr2021 at 04:00, the patient experienced nausea, vomiting, severe headaches and fever 102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (ADVIL) (200mg) (milligrams) and acetylsalicylic acid (ASPIRIN) (81mg). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, severe headaches and fever 102 (unspecified units) was resolved on unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, SARS-CoV-2 test
Clinical narrative: Dizziness; Weakness; Chills; Fatigue; Swelling of the neck; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0153) via an unspecified route of administration in the left arm on 07Apr2021 at 09:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fish oil (OMEGA 3) and cyanocobalamin (B 12), both taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced dizziness, weakness, chills, fatigue and swelling of the neck. On an unknown date in Apr2021, two weeks later, the patient experienced vertigo; fatigue and vertigo were present at the time of this report. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if any therapeutic measures were taken as a result of the events. On 19Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The clinical outcome of the events dizziness, weakness, chills and swelling of the neck were resolved with lasting effects on an unknown date in Apr2021, while fatigue and vertigo were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.